Plain-English translation of NCT07102160 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This clinical trial is evaluating a medical device called the Cleaner Vac® Thrombectomy System, which is designed to remove blood clots from deep veins in the legs. Researchers want to understand how well and how safely this device works for patients who have recently developed deep vein thrombosis—a potentially serious condition where blood clots form in the large veins of the leg. The study will track participants for up to 2 years to see how they recover.
Deep vein thrombosis can be painful, dangerous, and lead to long-term complications if not treated effectively. This trial exists to evaluate whether this new mechanical device offers a safe and effective alternative or complement to existing treatments for removing these clots quickly.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will undergo a procedure where the Cleaner Vac device is used to remove the blood clot from your leg vein. After the procedure, you will have follow-up appointments at hospital discharge, then at 1 month, 6 months, 12 months, and 24 months to monitor your recovery and check for any side effects or complications. The study will track how well the clot is removed, how you feel, and whether any new problems develop over time.
AI-generated summary from trial data · Aug 26, 2026 · Not medical advice
United States